Ropes & Gray: Client Novavax, Maker of COVID-19 Vaccine, Signs $1.4B Agreement With Sanofi
May 11, 2024
May 11, 2024
BOSTON, Massachusetts, May 11 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray represented Novavax Inc., in a co-exclusive licensing agreement with French pharmaceutical company Sanofi to sell Novavax COVID-19 vaccine and collaboration to create a combined global COVID-19 and influenza shot. Sanofi is also taking an equity stake of less than five percent in Novavax. The transaction was announced on May 10.
Under the agreement, Novavax will rece . . .
Ropes & Gray represented Novavax Inc., in a co-exclusive licensing agreement with French pharmaceutical company Sanofi to sell Novavax COVID-19 vaccine and collaboration to create a combined global COVID-19 and influenza shot. Sanofi is also taking an equity stake of less than five percent in Novavax. The transaction was announced on May 10.
Under the agreement, Novavax will rece . . .